Table: Kissei Pharm -2024/25 group results

Kissei Pharmaceutical

07/05/2025 08:30

May 7 (Reuters)- 
          Kissei Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           88.33           75.58          91.50        44.30    
               (+16.9 pct)     (+12.0 pct)    (+3.6 pct)    (+4.3 pct) 
  Operating        5.77            4.02           6.00         2.30    
               (+43.7 pct)                    (+3.9 pct)   (+29.1 pct) 
  Recurring        6.97            6.14           7.40         3.10    
               (+13.5 pct)    (+925.9 pct)    (+6.1 pct)   (+38.5 pct) 
  Net
  Net             11.96           11.16          12.30         6.20    
               (+7.2 pct)      (+6.0 pct)     (+2.8 pct)   (+18.1 pct) 
  EPS          274.21 yen      246.61 yen     297.07 yen    149.74 yen 
  Ann Div      100.00 yen       82.00 yen     120.00 yen               
  -Q2 Div       45.00 yen       41.00 yen      60.00 yen               
  -Q4 Div       55.00 yen       41.00 yen      60.00 yen               
  
  NOTE - Kissei Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T